C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2577102
The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO196, PRO217, PRO231, PRO236, PRO245, PRO246, PRO258, PRO287, PRO328, PRO344, PRO357, PRO526, PRO724, PRO731, PRO732, PRO1003, PRO1104, PRO1151, PRO1244, PRO1298, PRO1313, PRO1570, PRO1886, PRO1891, PRO4409, PRO5725, PRO5994, PRO6097, PRO7425, PRO10102, PRO10282, PRO61709 or PRO779 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.
La présente invention concerne des animaux transgéniques ainsi que des compositions et des méthodes en rapport avec la caractérisation de la fonction génique. Spécifiquement, cette invention concerne des souris transgéniques présentant des disruptions dans les gènes PRO196, PRO217, PRO231, PRO236, PRO245, PRO246, PRO258, PRO287, PRO328, PRO344, PRO357, PRO526, PRO724, PRO731, PRO732, PRO1003, PRO1104, PRO1151, PRO1244, PRO1298, PRO1313, PRO1570, PRO1886, PRO1891, PRO4409, PRO5725, PRO5994, PRO6097, PRO7425, PRO10102, PRO10282, PRO61709 ou PRO779. De telles études et caractérisations in vivo peuvent conduire à des identifications précieuses et à la découverte d'agents thérapeutiques et/ou de traitements utiles pour la prévention, l'amélioration ou l'infléchissement de maladies et ou de dysfonctionnements en rapport avec des disruptions géniques tels que troubles neurologiques, troubles cardio-vasculaires, endothéliaux ou angiogènes; anomalies oculaires, troubles de l'immunologie, troubles oncologiques, anomalies ou troubles du métabolisme osseux, troubles du métabolisme des lipides ou anomalies du développement.
Brennan Jane
Desauvage Frederic
Edwards Joel
Huang Wenhu
Montgomery Charles
Genentech Inc.
Lexicon Genetics Incorporated
Lexicon Pharmaceuticals Inc.
Smart & Biggar
LandOfFree
Novel gene disruptions, compositions and methods relating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel gene disruptions, compositions and methods relating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel gene disruptions, compositions and methods relating... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1543536